These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 10193748)

  • 1. Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
    Lip GY; Gibbs CR
    J Am Coll Cardiol; 1999 Apr; 33(5):1424-6. PubMed ID: 10193748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure and Virchow's triad: a neglected association.
    Sosin MD; Bhatia G; Davis RC; Lip GY
    Wien Med Wochenschr; 2003; 153(19-20):411-6. PubMed ID: 14648920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prothrombotic state in atrial fibrillation: pathophysiological and management implications.
    Khan AA; Lip GYH
    Cardiovasc Res; 2019 Jan; 115(1):31-45. PubMed ID: 30388199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention.
    De Lorenzo F; Saba N; Kakkar VV
    Drugs; 2003; 63(6):565-76. PubMed ID: 12656654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelium and atrial fibrillation. The prothrombotic state revisited.
    Freestone B; Lip GY
    Hamostaseologie; 2008 Oct; 28(4):207-12. PubMed ID: 18836646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.
    Wolberg AS; Aleman MM; Leiderman K; Machlus KR
    Anesth Analg; 2012 Feb; 114(2):275-85. PubMed ID: 22104070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hypertension confer a hypercoagulable state?
    Lip GY; Li-Saw-Hee FL
    J Hypertens; 1998 Jul; 16(7):913-6. PubMed ID: 9794730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and the prothrombotic state.
    Lip GY; Chin BS; Blann AD
    Lancet Oncol; 2002 Jan; 3(1):27-34. PubMed ID: 11908507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation in patients with heart failure.
    Bhatia RS; Ouzounian M; Tu JV; Liu PP; Lee DS
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):193-7. PubMed ID: 19689257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virchow's triad revisited: blood constituents.
    Chung I; Lip GY
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):449-54. PubMed ID: 15692259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
    Baker DW; Wright RF
    JAMA; 1994 Nov 23-30; 272(20):1614-8. PubMed ID: 7966873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of thromboembolism in association with atrial fibrillation.
    Yamashita T
    Circ J; 2007; 71 Suppl A():A40-4. PubMed ID: 17587738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.
    Watson T; Shantsila E; Lip GY
    Lancet; 2009 Jan; 373(9658):155-66. PubMed ID: 19135613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilated cardiomyopathy and role of antithrombotic therapy.
    Abdo AS; Kemp R; Barham J; Geraci SA
    Am J Med Sci; 2010 Jun; 339(6):557-60. PubMed ID: 20186041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
    Thatai D; Ahooja V; Pullicino PM
    Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral arterial disease and Virchow's triad.
    Bennett PC; Silverman SH; Gill PS; Lip GY
    Thromb Haemost; 2009 Jun; 101(6):1032-40. PubMed ID: 19492144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.